Robotically Assisted Single Anastomosis Duodenoileal Bypass after Previous Sleeve Gastrectomy Implementing High Valuable Technology for Complex Procedures

Table 1

Data showing preoperative and postoperative comorbidities, weight, and BMI at time of sleeve gastrectomy surgery (SG), at the R-SADI, and at last follow-up.

Patient	Age/gender; (years, M/F)	Weight and BMI at 1st SG; (Kg/m^2)	Comorbidities at 1st SG	Months between surgeries	Weight and BMI at R-SADI; (Kg, Kg/m^2)	Follow-up time (months)	Weight and BMI at last follow-up; (Kg, Kg/m^2)	Comorbidities at follow-up
1	34/M	49,87	None	14	91; 34,3	9	75; 28	None
2	59/M	57,66	HTA; OSAS + CPAP	16	103,2; 46,5	9	76; 33	HTA.
3	56/M	51,35	Fibromyalgia; DMT2 (insulin); HBP; DLP; Arthropathy	13	78,450; 34,9	3	72; 32	DMT2 (lower doses of insulin); HBP better

BMI: body mass index; M/F: male/female; SG: sleeve gastrectomy; R-SADI: robotic-single anastomosis duodenoileal bypass; GERD: gastroesophageal reflux disease; HBP: high blood pressure; DMT2: diabetes mellitus type 2; DLP: dyslipidemia.